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The human ether-a-go-go-related gene (HERG) potassium current (IHERG) has been shown to decrease in
amplitude following stimulation with Gq protein-coupled receptors (GqRs), such as a1-adrenergic and
M1-muscarinic receptors (a1R and M1R, respectively), at least partly via the reduction of membrane
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). The present study was designed to investigate the
modulation of HERG channels by PI(4,5)P2 and phosphatidylinositol4-phosphate 5-kinase (PI(4)P5-K), a
synthetic enzyme of PI(4,5)P2. Whole-cell patch-clamp recordings were used to examine the activity of
HERG channels expressed heterologously in Chinese Hamster Ovary cells. The stimulation of a1R with
phenylephrine or M1R with acetylcholine decreased the amplitude of IHERG accompanied by a signiﬁcant
acceleration of deactivation kinetics and the effects on IHERG were signiﬁcantly attenuated in cells
expressing PI(4)P5-K. The density of IHERG in cells expressing GqRs alone was signiﬁcantly increased by
the coexpression of PI(4)P5-K without signiﬁcant differences in the voltage dependence of activation and
deactivation kinetics. The kinase-deﬁcient substitution mutant, PI(4)P5-K-K138A did not have these
counteracting effects on the change in IHERG by M1R stimulation. These results suggest that the current
density of IHERG is closely dependent on the membrane PI(4,5)P2 level, which is regulated by PI(4)P5-K
and GqRs and that replenishing PI(4,5)P2 by PI(4)P5-K recovers IHERG.
© 2014 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The human ether-a-go-go-related gene (HERG) is known to
encode a Kþ channel with electrophysiological properties similar to
those of the rapid component of the delayed rectiﬁer Kþ current, Chinese hamster ovary; IKr,
qRs, Gq protein-coupled re-
TS, long QT syndrome; M1R,
sitol 4,5-bisphosphate; PI(4)
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. Production and hosting by Else(IKr) in the human heart (1, 2). IKr is essential for the proper repo-
larization of cardiac myocytes near the end of each action potential.
Therefore, the HERG channel activity contributes to cardiac repo-
larization and is an important determinant of the QT interval on
electrocardiograms. It is well known that excessive blockade of
HERG channels by antiarrhythmic or non-antiarrhythmic drugs can
lead to acquired long QT syndrome (LQTS) and torsade de pointes
(TdP) (3, 4) and the accidental combination of genetic mutation of
HERG channels and drugs appears to due to TdP (5)
The heart rate and contractility are continually altered in
response to changing cardiovascular demands and stress induced
by autonomic stimulation. The stimulation of autonomic receptors
coupled to Gq proteins, such as the muscarinic M1 receptor (M1R)
and a1-adrenergic receptor (a1R), activates phosphoinositide-
speciﬁc phospholipase C (PLC), leading to the hydrolysis of thevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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(PI(4,5)P2) to form inositol 1,4,5-trisphosphate (IP3) and diac-
ylglycerol (DAG) (6). It is well known that IP3 stimulates receptors
on intracellular Ca2þ stores to release Ca2þ and that DAG activates
protein kinase C (PKC).
In addition to the role of the precursors of these second mes-
sengers, PI(4,5)P2 itself plays a critical role in various cellular pro-
cesses, including regulation of many ion channels and transporters
(7, 8). A recent study reported that PI(4,5)P2 have dual effect on
Shaker potassium channels, namely, a gain-of-function effect on
the maximal current amplitude and a loss-of-function effect by
positive-shifting the activation voltage dependence (9). Evidence
has also been presented to show that PI(4,5)P2 controls both the
movement of the voltage sensor and the stability of the open pore
in HERG channels (10).
Phosphatidylinositol4-phosphate 5-kinase (PI(4)P5-K) is the
enzyme that catalyzes the phosphorylation of phosphatidylinositol
4-phosphate (PI(4)P) to PI(4,5)P2, thereby facilitating the replen-
ishment of PI(4,5)P2 following PLC-coupled receptor-mediated
depletion (8). Previous reports have shown that an increased as-
sociation between PI(4)P5-K and the cytoskeleton results in the
enhanced formation of PI(4,5)P2 and that the spatially and
temporally organized regulation of PI(4,5)P2 synthesis by PI(4)P5-K
enables dynamic and versatile PI(4,5)P2 signaling (11).
The present study was undertaken to investigate the function of
PI(4)P5-K in the regulation of HERG channels under basal condi-
tions and during GqRs stimulation based on the heterologous
expression of wild type of PI(4)P5-K and a kinase-deﬁcient sub-
stitution mutant, PI(4)P5-K-K138A (12).
Methods
Cell culture and transfection
Chinese hamster ovary (CHO) cells were maintained in DMEM/
Ham's F-12 supplemented with 10% fetal calf serum (GIBCO) and
antibiotics (100 UmL1 penicillin and 100 mg mL1 streptomycin)
in a humidiﬁed incubator gassed with 5% CO2 and 95% air at 37 C.
The cells were seeded onto 35-mm plastic culture dishes with
sterile glass coverslips (5 mm 3 mm) on the bottom and incu-
bated for 24e48 h. The CHO cells were transiently transfected with
the following cDNAs using Lipofectamine (Invitrogen): HERG
(kindly provided by Dr. M. Sanguinetti, University of Utah, Salt Lake
City, UT, USA), the type Ia isoform of PI(4)P5-K (tagged with the
hemagglutinin (HA) epitope, kindly provided by Dr. Oka, University
of Tokyo, Japan), human M1R (UMR cDNA Resource Center), human
a1AR (UMR cDNA Resource Center) and GFP (pEGFP, Clonetech).
The substitution mutant PI(4)P5-K-K138A cDNA was constructed
via oligonucleotide-directed mutagenesis using the QuikChange
Site-Directed Mutagenesis Kit (Agilent Technologies). The amount
of each cDNA used for transfection was as follows (mg dish1): 1.5
HERG, 1.0 PI(4)P5-K, 1.0 M1R, 1.0 a1R and 0.5 GFP. The cells were
grown on glass coverslips for 48 to 72 h after transfection, and only
GFP-positive cells were used for the electrophysiological studies.
Solutions and chemicals
The normal Tyrode solution contained (in mM); 140 NaCl, 5.4
KCl, 1.8 CaCl2, 0.5 MgCl2, 0.33 NaH2PO4, 5.5 glucose and 5.0 HEPES
(pH adjusted to 7.4 with NaOH) andwas used as a standard external
solution to measure IHERG. The control pipette solution consisted of
(in mM) 70 potassium aspartate, 50 KCl, 10 KH2PO4, 1 MgCl2, 3
Na2ATP (Sigma), 0.1 Li2-GTP (Roche Diagnostics), 5 EGTA and 5
HEPES (pH adjusted to 7.2with KOH). The concentration of free Ca2þ
andMg2þ in the pipette solutionwas calculated to be approximately1.51010 M (pCa¼ 9.8) and 3.7105 M (pMg¼ 4.4), respectively
(13,14). Acetylcholine (ACh, Sigma) or L-phenylephrine (Phe, Sigma)
was used at the desired ﬁnal concentration in the normal Tyrode
solution.
Whole-cell patch-clamp technique and data analysis
The cells were voltage-clamped using the whole-cell conﬁgura-
tion of the patch-clamp technique (15) with an EPC-8 patch-clamp
ampliﬁer (HEKA Elektronik, Lambrecht, Germany). The patch elec-
trodes were fabricated from glass capillaries (1.5 mm outer diam-
eter, 0.9 mm inner diameter; Narishige Scientiﬁc Instrument
Laboratory, Tokyo, Japan) using a Sutter P-97 microelectrode puller
(Novato, CA,USA), and the tipswereﬁre polishedusing amicroforge.
The patch electrodes had a resistance of 2.0e4.0 MU when ﬁlled
with the pipette solution. After gaining access to the cell interior (via
rupture of the patch membrane), the membrane potential was held
at 80 mV and repetitively (every 20 s) depolarized to a test po-
tential of þ10 mV for 2 s followed by a repolarizing step to60 mV
for 15 s before the IHERG became stable. All experiments were per-
formed at 34e36 C. The PatchMaster (HEKA) and IGORPro (ver. 6.2,
WaveMetrics) software programswere used for the data acquisition
and analysis. The cell membrane capacitance (Cm) of each cell was
calculated byﬁtting a single exponential function to the decay phase
of the transient capacitive current resulting from 5-mV hyper-
polarizing steps applied from a holding potential of 80 mV (16).
The current amplitude was divided by Cm to obtain the current
density (pA pF1). The concentration- response relationship for the
inhibition of IHERG by ACh was drawn according to the least-squares
ﬁt of the Hill equation: R¼ Rmax/[1þ (IC50/[agonist])nH], where Rmax
represents the maximal degree of inhibition expressed as a per-
centage, IC50 is the concentration giving a half-maximal inhibition
and nH is the Hill coefﬁcient. The voltage dependence of IHERG acti-
vationwas determined by ﬁtting the normalized IeV relationship of
the tail currents to a Boltzmann equation: IHERG, tail¼ 1/{1þ exp[(V1/
2 Vm)/k]}, where IHERG, tail is the tail current amplitude normalized
with reference to themaximumvaluemeasured at 10 mV, V1/2 is the
voltage at the half-maximal membrane voltage of activation or
inactivation,Vm is the testpotential and k is the slope factor. The time
course for decay of the IHERG tail current was ﬁtted with the sum of
two exponential functions: IHERG, decay ¼ Afast exp(t/tfast)þ Aslow
exp(t/tslow), where Afast and Aslow represent the amplitudes of the
fast and slow components, respectively, and tfast and tslow are time
constants for the fast and slowcomponents, respectively. The effects
of the agonist on IHERG were examined at least 3 min after
application.
Immunocytochemical analysis
CHO cells cotransfected with M1R and HERG with or without
HA-tagged PI(4)P5-K or PI(4)P5-K-K138A were ﬁxed with 4%
paraformaldehyde for 30min and permeabilized/blockedwith 0.2%
Triton X-100 and 2% BSA in PBS for 60 min at room temperature.
The permeabilized cells were incubatedwith rabbit polyclonal anti-
HA antibodies (1:500, MBL, Co.) overnight at 4 C. The cells were
then probed with an AlexaFluor® 546-conjugated secondary anti-
body (1:400, Molecular Probes-Invitrogen). Fluorescent signals
were analyzed using a confocal laser scanning system Clsi (Nikon)
on an Eclipse TE2000-E inverted microscope (Nikon).
Statistics
The data are presented as the mean± S.E.M., and n indicates the
number of cells studied. For single comparisons, Student's paired or
unpaired t-test was used. For multiple group comparisons, an
T. Kubo et al. / Journal of Pharmacological Sciences 127 (2015) 127e134 129analysis of variance (ANOVA)with Bonferroni adjusted LSD testwas
applied (SAS9.13; SAS Institute, Inc., Cary, NC). A value of P< 0.05
was considered to indicate a signiﬁcant difference.
Results
Effects of M1R stimulation on IHERG in the CHO cells
To examine the M1R-mediated modulation of HERG channels,
the whole-cell membrane current was recorded in the CHO cells
transiently transfected with HERG and M1R. Fig. 1A shows a repre-
sentative example of the effects of M1R stimulationwith 30 mMACh
on IHERG. IHERGwas elicited by2 s depolarizing steps to test potentials
of 70 to þ40 mV from a holding potential of 80 mV. The tail
currents were recorded with a step to 60 mV for 15 s. The bath
application of ACh gradually reduced the amplitude of IHERG during
the depolarizing step over three minutes. The inhibitory effects of
ACh on the tail current amplitude were concentration-dependent,
with a half-maximal effect observed at 0.39 mM and a maximum
inhibition of 25.7± 4.2% attained at 10 mM (Fig. 1B). Muscarinic
stimulation caused a positive shift in the voltage-dependence
of IHERG activation (Fig. 1C). The half-maximal activation voltage
(V1/2) was signiﬁcantly shifted from 19.1± 3.6 mV in control
to e 11.9± 4.3 mV during exposure to 30 mM ACh (n ¼ 4, P< 0.01).
The slope factor did not change signiﬁcantly. No inhibition of IHERG
by 30 mM ACh was observed in the cells not expressing M1R
(1.9± 2.5%, Fig.1B), indicating that ACh acts via a receptor-mediated
pathway.
The impact of M1R stimulation was also manifested in
the deactivation kinetics of IHERG. In the experiment shown in
Fig. 2A, we compared the time course of IHERG deactivation before
and during exposure to 30 mM ACh. The decay of the IHERG tail
currents recorded at potentials between 120 and 40 mV wasFig. 1. M1R stimulation reduces IHERG activation in the CHO cells. (A) Representative superim
after (right panel) 3-min exposure to 30 mM ACh. The membrane potential was stepped
to þ40 mV for 2 s in 10-mV steps followed by repolarization to 60 mV for 15 s. (B) Dose-
expressing HERG with M1R; n ¼ 6 for each concentration). The inhibitory actions of ACh wer
potential to þ10 mV for 2 s. The data points were ﬁtted by a Hill equation, yielding an IC50 o
HERG without M1R; n ¼ 3. (C) Voltage-dependent activation curves obtained by plotting
repolarizing steps to 60 mV after various test potentials. The data of the normalized tail c
ﬁlled circles: 30 mM ACh; n ¼ 4.reasonably well described by a two-exponential function. Both tfast
and tslow were appreciably decreased by M1R stimulation (left and
right panels of Fig. 2B, respectively), indicating that the deactiva-
tion of IHERG was accelerated by M1R stimulation. It should be
noted that the ratio of the fast component to the total components
(Afast / (Afastþ Aslow)) did not change signiﬁcantly (Fig. 2C).
Effects of expression of M1R and PI(4)P5-K on basal IHERG activity
Previous electrophysiological experiments have demonstrated
that PI(4,5)P2 exogenously applied through a patch electrode
directly modulates the function of HERG channels (17). To address
the question of whether a reduction in membrane PI(4,5)P2 un-
derlies the change in IHERG observed during M1R stimulation, we
coexpressed the channels together with PI(4)P5-K, which is
assumed to speciﬁcally and tonically elevate the membrane PI(4,5)
P2 levels or with a kinase-deﬁcient substitution mutant, PI(4)P5-K-
K138A (12). Before conducting the electrophysiological experi-
ments, the expressions of PI(4)P5-K were examined using an
immunocytochemical assay with a speciﬁc antibody against the
HA-epitope tag fused to the N-terminus of the kinase. As illustrated
in Fig. 3B, PI(4)P5-K and PI(4)P5-K-K138A were expressed on the
plasma membrane with a broad subcellular distribution in most
cells, consistent with previously reported results (18). There were
no differences between the cells with or without expression ofM1R.
In addition, no positive signal was detected in the cells without
transfection of PI(4)P5-K or PI(4)P5-K-K138A (negative control).
We then examined the impact of M1R and PI(4)P5-K or PI(4)P5-
K-K138A expression on the basal IHERG amplitude (Fig. 3A). The
current density was evaluated by measuring the peak amplitude of
the tail currents at 60 mV after a test potential to þ10 mV for 2 s.
In cells expressing M1R, the current density of IHERG (23.7± 2.5 pA
pF1, n ¼ 44) was signiﬁcantly smaller than that observed in theposed current traces of IHERG in a cell expressing HERG and M1R before (left panel) and
from a holding potential of 80 mV to various test potentials ranging from 70 mV
response relationship for the ACh induced inhibition of IHERG (Filled circles: CHO cells
e evaluated by measuring the peak amplitude of the tail currents at 60 mV after a test
f 0.39 ± 0.15 mM and a Hill coefﬁcient of 0.94± 0.29. Open circles: CHO cells expressing
the peak tail current amplitudes of IHERG as a function of test potentials during the
urrent amplitudes of IHERG were ﬁtted by a Boltzmann equation. Open circles: control,
Fig. 2. M1R stimulation accelerates deactivation kinetics. (A) Representative superimposed current traces of IHERG in a cell expressing HERG and M1R, recorded before (left panel)
and after (right panel) 3-min exposure to 30 mM ACh. The membrane potential was stepped from a holding potential of 80 mV to þ40 mV for 1 s and then stepped to a potential
between 120 and 40 mV for 5 s. The inset of A shows the normalized tail current traces elicited upon repolarization to 70 mV following 1 s depolarization to þ40 mV before
(black) and during (grey) exposure to 30 mM ACh. (B) Fast (tfast) and slow (tslow) time constants of deactivation (left and right panels, respectively), obtained by ﬁtting the tail
current to two exponential functions before (open circles) and during (ﬁlled circles) exposure to 30 mM ACh. *P< 0.05 compared with the control value (Student’s paired t-test,
n ¼ 5). (C) The ratio of Afast to the total components (Afastþ Aslow) of deactivation before (open circles) and during (ﬁlled circles) exposure to 30 mM ACh.
Fig. 3. Characteristics of CHO cells expressing HERG with or without coexpressing
M1R, PI(4)P5-K or in combination of both (A) Current density of HERG channels in the
CHO cells. Current density of CHO cells expressing HERGwith or without M1R and PI(4)
P5-K were evaluated by measuring the peak amplitude of the tail currents at 60 mV
after a test potential to þ10 mV for 2 s. CHO cells expressing HERG þ M1R (open bar;
n ¼ 44), HERG þM1R þ PI(4)P5-K (ﬁlled bar; n ¼ 29), HERG þM1R þ PI(4)P5-K-K138A
(grey bar; n ¼ 23), HERG (horizontal striped bar; n ¼ 21) or HERG þ PI(4)P5-K (vertical
striped bar; n ¼ 14). *: P < 0.05, **: P< 0.01 compared with the control value (Bon-
ferroni adjusted LSD test). (B) Immunostaining for PI(4)P5-K or PI(4)P5-K-K138A in the
CHO cells. The protein expression was conﬁrmed by immunostaining with anti-HA
antibodies using a confocal laser scanning microscope. Scale Bar, 20 mm.
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P< 0.01). These changes in the activity of IHERG may arise from the
constitutive activity of M1R, even in the absence of an agonist, as
has been reported for the tonic stimulation of phosphoinositide
hydrolysis in the cells transfected with M1R (19). The additional
heterologous expression of PI(4)P5-K in cells expressing M1R
markedly restored the IHERG amplitude (36.1± 4.6 pA pF1, n ¼ 29,
P< 0.05). In contrast, the expression of PI(4)P5-K-K138A did not
restore the IHERG amplitude (26.5± 3.8 pA pF1, n ¼ 23). Assuming
that membrane PI(4,5)P2 is reduced by the M1R expression, which
is replenished by over-expression of PI(4)P5-K, these results sug-
gest that the basal activity of IHERG is strongly dependent on the
level of membrane PI(4,5)P2. However, PI(4)P5-K itself had little, if
any, effect on the amplitude or voltage-dependent activation of
IHERG (Fig. 3 and Table 1). In addition, there were no differences in
the deactivation kinetics of the cells with or without an expression
of M1R and PI(4)P5-K (Table 1).
PI(4)P5-K attenuates IHERG modulation via M1R and a1R stimulation
We addressed the question as to whether the PI(4)P5-K
expression affects the M1R-mediated modulation of IHERG. Fig. 4
shows the results of the typical experiments examining the ef-
fects of M1R stimulation on IHERG in the cells expressing with or
without PI(4)P5-K or PI(4)P5-K-K138A. Bath application of 30 mM
ACh inhibited the tail current of IHERG by 7.4± 1.7% in the cells
expressing of PI(4)P5-K (n ¼ 8), which is signiﬁcantly smaller than
that (19.0± 2.7%, n ¼ 12, P< 0.01) observed in the cells without a
expression of the kinase (Fig. 4D). In addition, neither the V1/2 shift
for IHERG activation nor the acceleration of deactivation kinetics
was caused by M1R stimulation in cells expressing PI(4)P5-K
(Fig. 4B and C). In contrast, PI(4)P5-K-K138A did not have these
counteracting effects on the change in IHERG induced by M1R
stimulation. Therefore the counteracting effects of PI(4)P5-K
Table 1
Kinetics of the activation and deactivation of IHERG in the CHO cells expressing HERG with or without M1R, PI(4)P5-K and PI(4)P5-K-K138A.
Activation Deactivation
V1/2 (mV) k (mV) n tfast (s) tslow (s) Afast / (Afastþ Aslow) n
HERG þ M1R 18.1± 2.5 6.7± 0.3 9 0.14± 0.02 1.04± 0.17 0.46± 0.05 11
HERG þ M1R þ PI(4)P5-K 18.3± 3.5 6.5± 0.2 8 0.15± 0.01 1.00± 0.11 0.49± 0.05 8
HERG þ M1R þ PI(4)P5-K-K138A 20.0± 1.9 7.4± 0.3 7 0.18± 0.04 1.14± 0.15 0.33± 0.07 5
HERG 14.3± 2.3 6.4± 0.9 5 0.14± 0.02 0.97± 0.19 0.47± 0.05 7
HERG þ PI(4)P5-K 15.2± 2.8 7.0± 0.5 6 0.13± 0.02 0.86± 0.13 0.44± 0.06 7
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ates the muscarinic modulation of IHERG.
In the heart, PI(4,5)P2 hydrolysis is associated with a1R stimu-
lation. Recent studies have revealed that a1-adrenergic stimulation
produces a reduction in IHERG (20, 21), which has been implicated in
ventricular arrhythmias triggered by autonomic activity. In another
set of experiments, we examined the effects of PI(4)P5-K on the a1-
adrenergic modulation of IHERG. As demonstrated in Fig. 5A, in cells
not expressing PI(4)P5-K, the stimulation of a1R with 30 mM Phe
obviously inhibited the IHERG amplitude, which was accompanied
by a positive signiﬁcant shift of V1/2 in the voltage-dependent
activation from 19.6± 3.2 mV in control to 9.2± 4.4 mV (n ¼ 5,
Fig. 5C, P< 0.05). On the other hand, in cells transfected with PI(4)
P5-K, the IHERG modulation by a1R stimulation was considerably
attenuated (Fig. 5A). The percentage inhibition of the tail current in
the control cells was 23.3± 6.4% (n ¼ 7), which was signiﬁcantly
attenuated to 8.4± 2.3% (n ¼ 12, P< 0.05) by the expression of PI(4)
P5-K (Fig. 5B). In addition, no obvious shifts in the activation curve
were found in the cells expressing the kinase (Fig. 5D). It is note-
worthy that the expression of a1R resulted in a reduction in the
basal current density of IHERG (23.1± 4.82 pA pF1, n ¼ 16), which
was markedly restored by the coexpression of PI(4)P5-K (38.1± 4.7
pA pF1, n ¼ 22, Fig. 5E, P< 0.05). The deactivation kinetics of IHERG
was accelerated by a1R stimulation, which was also reversed by the
PI(4)P5-K coexpression (data not shown). These observations were
similar to those observed upon M1R stimulation of IHERG.
Discussion and conclusions
It has been demonstrated that membrane PI(4,5)P2 modulates
the function of HERG channels (17), although the physiological
relevance of this modulation is still not fully understood. The stim-
ulation of GqRs, which leads to depletion of membrane PI(4,5)P2
(22), may be an appropriate intervention for evaluating the signiﬁ-
cance of the PI(4,5)P2-mediated regulation of HERG channels under
physiological and/or pathophysiological conditions. In the present
study, we investigated the modulation of IHERG by the membrane
PI(4,5)P2 level,whichwas regulated by the stimulation ofGqRs (M1R
and a1R) and/or PI(4)P5-K activity, using a heterologous expression
system in theCHO cells. Our results showed that i) the stimulation of
M1R or a1R decreased the amplitude of IHERG, which was accompa-
nied by a signiﬁcant positive shift of the activation curve and ac-
celeration of deactivation kinetics (Figs. 1, 2 and 5), ii) the density of
IHERG was decreased by the expression of M1R or a1R alone, which
was reversed by the coexpression of PI(4)P5-K, but not by a kinase-
deﬁcient substitution mutant, PI(4)P5-K-K138A (Fig. 3) and iii) the
inhibitory effects of M1R and a1R on IHERG were signiﬁcantly atten-
uated by the coexpression of PI(4)P5-K (Figs. 4 and 5).
Modulation of HERG channels via GqRs stimulation
Consistent with our present results, the decrease observed in
the response to GqRs stimulation has also been reported for IHERG
heterologously expressed inmammalian cell lines (17, 21) as well asnative IKr present in the HL-1 murine cardiac cell line and rabbit
cardiac myocytes (20, 23). Interestingly, the degree of current in-
hibition is similar (up to 40%) between recombinant cells and car-
diomyocytes, thus suggesting that the present experiments using a
heterologous expression system may provide a suitable model for
investigating the effects of Gq-coupled receptor stimulation on
native IKr.
Previous studies have suggested that the depletion of the
membrane PI(4,5)P2 content contributes to the IHERG inhibition
mediated via the stimulation of GqRs (17, 24). This hypothesis is
based on the following experimental evidence: i) IHERG inhibition
via GqRs is attenuated by the intracellular loading of exogenous
PI(4,5)P2 and ii) the recovery of IHERG from inhibition is largely
retarded by wortmannin, an inhibitor of PI(4)P5-K critically
involved in the synthesis of PI(4,5)P2. In the present study, we
found that the exogenous expression of PI(4)P5-K, a key enzyme
catalyzing the limiting step of the PI(4,5)P2 synthetic pathway, also
attenuated the reduction of IHERG during the stimulation ofM1R and
a1R (Figs. 4 and 5). Because the membrane PI(4,5)P2 content is
elevated by PI(4)P5-K expression (25), our ﬁndings provide further
evidence that the modulation of IHERG by GqRs is closely related to
the membrane PI(4,5)P2 level.
In our study, the current density of IHERG was reduced by the
GqRs expression itself, which was signiﬁcantly reversed by the
coexpression of PI(4)P5-K (Fig. 3A). We suggest that the basal ac-
tivity of exogenous GqRs reduces the membrane PI(4,5)P2 level,
even in the absence of agonist stimulation, thereby resulting in a
reduction of IHERG. Previous studies have demonstrated that the
expressions of M1R and a1R are accompanied by the accumulation
of cellular IP3 and an elevation in [Ca2þ]i (19) and that blockers for
these receptors function as inverse agonists in recombinant cells
(26). These observations indicate the constitutive activity of exog-
enously expressed M1R and a1R. Interestingly, there were no sig-
niﬁcant differences in deactivation kinetics between the cells with
or without an exogenous expression of M1R or PI(4)P5-K (Table 1),
despite the differences in current density (Fig. 3A). These results
may be explained as follows: i) the differences in kinetics among
these cells are too small to detect, ii) other regulatory factors or
signaling molecules are involved in the modulation of the kinetics
of IHERG induced by the stimulation of GqRs. At present, there is a
controversy as for a role of PKC activity. Previous studies have
provided evidence for the potential roles of PKC (21) and insensi-
tivity to PKC inhibitors (17, 27) in the regulation of the IHERG
amplitude. Further research is thus required to examine whether
other regulatory factors or signaling molecules affect the deacti-
vation of IHERG during the stimulation of GqRs.
Effects of the PI(4)P5-K expression on IHERG
It has been reported that PI(4)P5-K can increase the membrane
PI(4,5)P2 pool in neurons (25). On the other hand, the expression of
PI(4)P5-K failed to enhance the basal density of IHERG in cells
without exogenous M1R and a1R in our study (Fig. 3A). Similarly, in
rat atrial myocytes, the PI(4)P5-K expression has no appreciable
Fig. 4. PI(4)P5-K reverses the HERG current reduction induced by M1R stimulation. (A) Representative superimposed current traces of IHERG in a cell expressing HERG and M1R with or without PI(4)P5-K or PI(4)P5-K-K138A before (left
panel) and after (right panel) 3-min exposure to 30 mM ACh. The membrane potential was stepped from a holding potential of 80 mV to various test potentials ranging from 70 mV to þ40 mV for 2 s in 10-mV steps followed by
repolarization to 60 mV for 4 s. (B) Voltage-dependent activation curves obtained by plotting the peak tail current amplitudes of IHERG during repolarizing steps to60 mV after various test potentials. The data of the normalized tail
current amplitudes of IHERG were ﬁtted by a Boltzmann equation. Open circles: control, ﬁlled circles: 30 mM ACh. M1Rþ PI(4)P5-K; n ¼ 8, M1Rþ PI(4)P5-K-K138A; n ¼ 6. (C) The tfast and tslow of deactivation during repolarizing steps
to e 60 mV following depolarization to þ10 mV were obtained by ﬁtting the tail current to two exponential functions before (open bars) and during (ﬁlled bars) exposure to 30 mM ACh. M1R; n ¼ 5, M1Rþ PI(4)P5-K; n ¼ 5, M1Rþ PI(4)
P5-K-K138A; n ¼ 4. (D) Percent inhibition of the peak tail current amplitudes of IHERG induced by 30 mM ACh in the cells expressing M1R (open bar; n ¼ 12) with PI(4)P5-K (ﬁlled bar; n ¼ 11) or with PI(4)P5-K K-K138A (grey bar; n ¼ 10).
**P< 0.01, *P< 0.05 compared with the control value (Bonferroni adjusted LSD test).
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Fig. 5. Effects of a1R stimulation on the HERG current in the CHO cells with or without a PI(4)P5-K expression. (A) Representative current traces from a cell expressing HERG and a1R
with or without PI(4)P5-K before (left panel) and after (right panel) 3-min exposure to 30 mM Phe. The membrane potential was stepped from a holding potential of 80 mV to
various test potentials ranging from 70 mV to þ40 mV for 2 s in 10-mV steps followed by repolarization to 60 mV for 15 s. (B) Percent inhibition of the peak tail current
amplitudes of IHERG induced by 30 mM Phe during repolarizing steps to 60 mV following depolarization to þ10 mV in the cells with (ﬁlled bar; n ¼ 12) or without an expression of
PI(4)P5-K (open bar; n ¼ 7). *P < 0.05 compared with the control value (Student’s unpaired t-test). (C, D) Voltage-dependent activation curves obtained by plotting the peak tail
current amplitudes of IHERG during repolarizing steps to 60 mV following depolarization to various test potentials in the cells expressing HERG and a1R with (D) or without PI(4)
P5-K (C). The data of the normalized tail current amplitudes of IHERG were ﬁtted by a Boltzmann equation. Open circles: control, ﬁlled circles: 30 mM Phe; n ¼ 5, 4. (E) Current density
of CHO cells expressing a1R and HERG with or without PI(4)P5-K were evaluated by measuring the peak amplitude of the tail currents at 60 mV after a test potential toþ10 mV for
2 s. Open bars: CHO cells expressing HERG and a1R (n ¼ 16), ﬁlled bars: CHO cells expressing HERG, a1R and PI(4)P5-K (n¼ 22). *P < 0.05 compared with the control value (Student’s
unpaired t-test)
T. Kubo et al. / Journal of Pharmacological Sciences 127 (2015) 127e134 133effects on the basal activity of G protein-gated inward rectiﬁer Kþ
current (28). One possible explanation for this phenomenon is that
the PI(4,5)P2 level in basal conditions is high enough to fully acti-
vate IHERG. This idea is in apparent contrast with previous obser-
vations in which IHERG was found to be enhanced by adding PI(4,5)
P2 inside the cell (17). It has been reported that the intracellular
loading of excess amounts of negatively charged PI(4,5)P2 results in
the perturbation of various protein functions due to nonspeciﬁc
electrostatic interactions (29). In addition, Rodriguez reported the
differential effects of PI(4,5)P2 and its analog diC8- PI(4,5)P2 on
IHERG (10). In contrast to the actions of PI(4,5)P2 applied through the
patch pipette, the expression of PI(4)P5-K is expected to increase
the membrane PI(4,5)P2 content via a physiological synthetic
pathway.
Clinical implications
A decrease in IKr due to genetic mutations in HERG and/or an
excessive blockade by either antiarrhythmic or non-antiarrhythmic
drugs is associated with type 2 LQTS (LQT2), which causes fatal
arrhythmia TdP. It is well known that, in patients with LQT2, TdP is
often triggered by alterations in autonomic activity during auditory
stimuli (alarm clock, etc.), and the involvement of IKr inhibition due
to a1R stimulation has been suggested (20). Our ﬁndings that
exogenous PI(4)P5-K effectively prevents the inhibition of IKr in
response to the stimulation of a1R without kinetic changes in HERG
channel may provide a potentially novel strategy for developing of
a new class of antiarrhythmic drugs. It is therefore reasonable to
suggest that PI(4)P5-K is an attractive target for the treatment of
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